294 related articles for article (PubMed ID: 35962436)
21. NDUFA4L2 is a novel biomarker for colorectal cancer through bioinformatics analysis.
Lin Y; Xie H; Zhao W; Li Y; Zhang Z
Medicine (Baltimore); 2023 Nov; 102(44):e35893. PubMed ID: 37933010
[TBL] [Abstract][Full Text] [Related]
22. The possible role of SRMS in colorectal cancer by bioinformatics analysis.
Zhang J; Liu W; Feng S; Zhong B
World J Surg Oncol; 2021 Nov; 19(1):326. PubMed ID: 34781983
[TBL] [Abstract][Full Text] [Related]
23. A Novel Prognostic Score Based on
Wang W; Sun JF; Wang XZ; Ying HQ; You XH; Sun F
Pharmgenomics Pers Med; 2020; 13():735-747. PubMed ID: 33364813
[TBL] [Abstract][Full Text] [Related]
24. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
[TBL] [Abstract][Full Text] [Related]
26. Reduced expression of MTUS1 mRNA is correlated with poor prognosis in bladder cancer.
Xiao J; Chen JX; Zhu YP; Zhou LY; Shu QA; Chen LW
Oncol Lett; 2012 Jul; 4(1):113-118. PubMed ID: 22807972
[TBL] [Abstract][Full Text] [Related]
27. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Model of Colorectal Cancer Constructed by Eight Immune-Related Genes.
Wen S; He L; Zhong Z; Mi H; Liu F
Front Mol Biosci; 2020; 7():604252. PubMed ID: 33330631
[TBL] [Abstract][Full Text] [Related]
29. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
[TBL] [Abstract][Full Text] [Related]
30. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
31. Long Noncoding RNA KCNQ1OT1 is a Prognostic Biomarker and mediates CD8
Lin ZB; Long P; Zhao Z; Zhang YR; Chu XD; Zhao XX; Ding H; Huan SW; Pan YL; Pan JH
Int J Biol Sci; 2021; 17(7):1757-1768. PubMed ID: 33994860
[No Abstract] [Full Text] [Related]
32. High expression of CDKN2A is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy.
Dong Y; Zheng M; Wang X; Yu C; Qin T; Shen X
BMC Cancer; 2023 Nov; 23(1):1097. PubMed ID: 37950153
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer.
Kuai W; Xu X; Yan J; Zhao W; Li Y; Wang B; Yuan N; Li Z; Jia Y
Biomed Res Int; 2020; 2020():5294043. PubMed ID: 32509862
[TBL] [Abstract][Full Text] [Related]
34. Ano1 is a Prognostic Biomarker That is Correlated with Immune Infiltration in Colorectal Cancer.
Chen J; Wang H; Peng F; Qiao H; Liu L; Wang L; Shang B
Int J Gen Med; 2022; 15():1547-1564. PubMed ID: 35210827
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of LRRC19 Is Associated with Poor Prognosis in Colorectal Cancer.
Wang YJ; Liu M; Jiang HY; Yu YW
J Oncol; 2022; 2022():5848823. PubMed ID: 35794979
[TBL] [Abstract][Full Text] [Related]
36. Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study.
Rogler A; Hoja S; Giedl J; Ekici AB; Wach S; Taubert H; Goebell PJ; Wullich B; Stöckle M; Lehmann J; Petsch S; Hartmann A; Stoehr R
BMC Cancer; 2014 Mar; 14():214. PubMed ID: 24650297
[TBL] [Abstract][Full Text] [Related]
37. Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
Hammad A; Elshaer M; Tang X
Math Biosci Eng; 2021 Oct; 18(6):8997-9015. PubMed ID: 34814332
[TBL] [Abstract][Full Text] [Related]
38. Exosomal MEF2C's Association With the Progression of CRC in Regulating CD36 Transcription.
Wang M; Jiang Y; Fan ZL; Zhang N; Liang J; Zheng Z
Altern Ther Health Med; 2023 Jan; 29(1):198-209. PubMed ID: 36074971
[TBL] [Abstract][Full Text] [Related]
39. INHBB Is a Novel Prognostic Biomarker Associated with Cancer-Promoting Pathways in Colorectal Cancer.
Yuan J; Xie A; Cao Q; Li X; Chen J
Biomed Res Int; 2020; 2020():6909672. PubMed ID: 33083477
[TBL] [Abstract][Full Text] [Related]
40. High expression of meningioma 1 is correlated with reduced survival rates in colorectal cancer patients.
Ho YJ; Liu FC; Chang J; Shi B; Yeh KT; Lin YM; Lu JW
Acta Histochem; 2019 Jul; 121(5):628-637. PubMed ID: 31133374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
